Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade “A” Success Rate for First-Line Helicobacter pylori Eradication

This prospective study was to assess the efficacy of nonbismuth containing quadruple therapy as first-line H. pylori treatment and to determine the clinical factors influencing patient outcome. We enrolled 200 H. pylori-infected naïve patients. They were prescribed either a 7-day nonbismuth containi...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Biomed Res Int
Главные авторы: Tai, Wei-Chen, Liang, Chih-Ming, Lee, Chen-Hsiang, Chiu, Chien-Hua, Hu, Ming-Luen, Lu, Lung-Sheng, Kuo, Yuan-Hung, Kuo, Chung-Mou, Yen, Yi-Hao, Kuo, Chung-Huang, Chiou, Shue-Shian, Wu, Keng-Liang, Chiu, Yi-Chun, Hu, Tsung-Hui, Chuah, Seng-Kee
Формат: Artigo
Язык:Inglês
Опубликовано: Hindawi Publishing Corporation 2015
Предметы:
Clinical Study
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4452293/
https://ncbi.nlm.nih.gov/pubmed/26090428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/623732
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы